NDC 73562-104 – Viokace

Pancrelipase Lipase 10440 [USP'U]/1; Pancrelipase Protease 39150 [USP'U]/1; Pancrelipase Amylase 39150 [USP'U]/1 · Tablet · Oral

Human Prescription Drug

Product NDC73562-104

Product details

Brand name
Viokace
Generic name
Pancrelipase
Labeler
Aimmune Therapeutics, Inc.
Dosage form
Tablet
Route
Oral
Marketing category
BLA · BLA022542
Marketed since
March 1, 2021
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Viokace →

Package NDC codes (1)

Package NDCDescriptionSince
73562-104-101 BOTTLE in 1 CARTON (73562-104-10) / 100 TABLET in 1 BOTTLEMar 1, 2021

Other Viokace products